Feasibility of Indirect Treatment Comparisons Between Niraparib Plus Abiraterone Acetate and Other First-Line Poly ADP-Ribose Polymerase Inhibitor Treatment Regimens for Patients with BRCA1/2 Mutation-Positive Metastatic Castration-Resistant Prostate Cancer

1. De Santis, M.
2. Breijo, S.M.
3. Robinson, P.
4. Capone, C.
5. Pascoe, K.
6. Van Sanden, S.
7. Hashim, M.
8. Trevisan, M.
9. Daly, C.
10. Reitsma, F.
11. van Beekhuizen, S.
12. Ruan, H.
13. Heeg, B.
14. Verzoni, E.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1007/S12325-024-02918-6 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus